A carregar...
Molecular basis of pharmacotherapies for cognition in Down syndrome
Intellectual disability (ID) in Down syndrome (DS) ranges from low normal to severely impaired, and has a significant impact on the quality of life of the individuals affected and their families. Because the incidence of DS remains at approximately one in 700 live births and the life span is now >...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2815198/ https://ncbi.nlm.nih.gov/pubmed/19963286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2009.10.010 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|